NO20051794L - Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike - Google Patents

Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike

Info

Publication number
NO20051794L
NO20051794L NO20051794A NO20051794A NO20051794L NO 20051794 L NO20051794 L NO 20051794L NO 20051794 A NO20051794 A NO 20051794A NO 20051794 A NO20051794 A NO 20051794A NO 20051794 L NO20051794 L NO 20051794L
Authority
NO
Norway
Prior art keywords
preparation
processes
epothilone derivatives
novel intermediates
optionally substituted
Prior art date
Application number
NO20051794A
Other languages
English (en)
Norwegian (no)
Other versions
NO20051794D0 (no
Inventor
Olivier Loiseleur
Guido Koch
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9944042&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20051794(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20051794D0 publication Critical patent/NO20051794D0/no
Publication of NO20051794L publication Critical patent/NO20051794L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20051794A 2002-09-13 2005-04-12 Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike NO20051794L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0221312.2A GB0221312D0 (en) 2002-09-13 2002-09-13 Organic compounds
PCT/EP2003/010171 WO2004024735A2 (en) 2002-09-13 2003-09-12 A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same

Publications (2)

Publication Number Publication Date
NO20051794D0 NO20051794D0 (no) 2005-04-12
NO20051794L true NO20051794L (no) 2005-04-12

Family

ID=9944042

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051794A NO20051794L (no) 2002-09-13 2005-04-12 Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike

Country Status (29)

Country Link
US (1) US7470792B2 (de)
EP (1) EP1539768B1 (de)
JP (1) JP4628102B2 (de)
KR (1) KR20050042500A (de)
CN (1) CN100522968C (de)
AR (1) AR041231A1 (de)
AT (1) ATE373663T1 (de)
AU (2) AU2003267349B2 (de)
BR (1) BR0314263A (de)
CA (1) CA2497119C (de)
CY (1) CY1107794T1 (de)
DE (1) DE60316456T2 (de)
DK (1) DK1539768T3 (de)
EC (1) ECSP055652A (de)
ES (1) ES2290489T3 (de)
GB (1) GB0221312D0 (de)
IL (1) IL166829A (de)
MX (1) MXPA05002785A (de)
MY (1) MY140442A (de)
NO (1) NO20051794L (de)
NZ (1) NZ538612A (de)
PE (1) PE20050052A1 (de)
PL (1) PL375039A1 (de)
PT (1) PT1539768E (de)
RU (2) RU2343155C2 (de)
SG (1) SG155770A1 (de)
TW (1) TWI289563B (de)
WO (1) WO2004024735A2 (de)
ZA (1) ZA200501008B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242469B1 (en) 1996-12-03 2001-06-05 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
WO2004018478A2 (en) 2002-08-23 2004-03-04 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
CN103037903A (zh) 2010-05-18 2013-04-10 天蓝制药公司 用于治疗自身免疫性疾病或其它疾病的组合物和方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU716610B2 (en) * 1996-08-30 2000-03-02 Novartis Ag Method for producing epothilones, and intermediate products obtained during the production process
US6441186B1 (en) 1996-12-13 2002-08-27 The Scripps Research Institute Epothilone analogs
US6380394B1 (en) * 1996-12-13 2002-04-30 The Scripps Research Institute Epothilone analogs
EP1201666A3 (de) * 1997-02-25 2003-03-05 Gesellschaft für biotechnologische Forschung mbH (GBF) Seitenkettenmodifizierte Epothilone
US6498257B1 (en) 1998-04-21 2002-12-24 Bristol-Myers Squibb Company 2,3-olefinic epothilone derivatives
GB9810659D0 (en) * 1998-05-18 1998-07-15 Ciba Geigy Ag Organic compounds
AU2795000A (en) * 1998-12-22 2000-07-12 Novartis Ag Epothilone derivatives and their use as antitumor agents
JP2003505459A (ja) * 1999-07-22 2003-02-12 シエーリング アクチエンゲゼルシャフト エポチロンｂおよび誘導体製造のための方法、ならびにこの方法のための中間製品
US6593115B2 (en) * 2000-03-24 2003-07-15 Bristol-Myers Squibb Co. Preparation of epothilone intermediates
AU2002213248A1 (en) * 2000-10-13 2002-04-22 The University Of Mississipi Synthesis of epothilones and relates analogs
WO2004012735A2 (en) * 2002-07-31 2004-02-12 Schering Ag New effector conjugates, process for their production and their pharmaceutical use

Also Published As

Publication number Publication date
JP4628102B2 (ja) 2011-02-09
CA2497119C (en) 2011-08-02
AR041231A1 (es) 2005-05-11
NO20051794D0 (no) 2005-04-12
TW200413388A (en) 2004-08-01
AU2003267349A1 (en) 2004-04-30
ECSP055652A (es) 2005-05-30
CY1107794T1 (el) 2013-06-19
RU2005110925A (ru) 2006-01-20
AU2003267349B2 (en) 2008-05-01
SG155770A1 (en) 2009-10-29
MXPA05002785A (es) 2005-06-03
ES2290489T3 (es) 2008-02-16
TWI289563B (en) 2007-11-11
JP2006511469A (ja) 2006-04-06
PE20050052A1 (es) 2005-03-28
MY140442A (en) 2009-12-31
US7470792B2 (en) 2008-12-30
AU2008203451A1 (en) 2008-08-21
ATE373663T1 (de) 2007-10-15
CA2497119A1 (en) 2004-03-25
WO2004024735A3 (en) 2004-07-22
EP1539768A2 (de) 2005-06-15
RU2343155C2 (ru) 2009-01-10
RU2404985C2 (ru) 2010-11-27
IL166829A (en) 2011-01-31
RU2008129613A (ru) 2010-01-27
BR0314263A (pt) 2005-07-05
GB0221312D0 (en) 2002-10-23
WO2004024735A2 (en) 2004-03-25
DE60316456D1 (de) 2007-10-31
PL375039A1 (en) 2005-11-14
DE60316456T2 (de) 2008-06-19
KR20050042500A (ko) 2005-05-09
CN100522968C (zh) 2009-08-05
NZ538612A (en) 2008-01-31
PT1539768E (pt) 2007-12-17
DK1539768T3 (da) 2008-01-07
HK1078853A1 (en) 2006-03-24
CN1681824A (zh) 2005-10-12
US20060106073A1 (en) 2006-05-18
EP1539768B1 (de) 2007-09-19
ZA200501008B (en) 2006-12-27

Similar Documents

Publication Publication Date Title
Abid et al. Synthesis and antiamoebic activities of 1-N-substituted cyclised pyrazoline analogues of thiosemicarbazones
NO20042584L (no) Dibenzylaminforbindelser og farmasoytisk anvendelse derav
NO20081464L (no) 1-heterocyklusulfonyl, 2-aminometyl, 5-(hetero-)aryl subsidiert 1-H-pyrrol-derivater som syresekresjonsinhibitorer
WO2003045929A1 (en) Bicyclic derivative, process for producing the same, and use
EA200602170A1 (ru) Производные пиперидина, композиции на их основе, способы их применения
NO20080717L (no) Oksimderivat og fremgangsmate for fremstilling av dette
ÖZDEMİR et al. Novel analogues of 2-pyrazoline: synthesis, characterization, and antimycobacterial evaluation
NO20065537L (no) Heterosykliske amidforbindelser og anvendelse derav som en MMP-13-inhibitor
CA2213124A1 (en) Benzoyl derivatives
MY158055A (en) Tetrahydroquinoline derivatives and a process for preparing the same.
NO20076660L (no) Fremgangsmate for fremstilling av rosuvastatin og mellomprodukter
YU47555B (sh) Derivati tetrahidrobenzimidazola i postupak za njihovo dobijanje
El‐Gaby Syntheses of hitherto unknown Thiazole, Ylidene and Pyridinethione derivatives having a Piperidin‐1‐yl moiety and their use as antimicrobial agents
MXPA04002570A (es) Compuestos que inhiben la liberacion de citocinas inflamatorias.
ATE491704T1 (de) 4-ä2-(cycloalkylamino)pyrimidin-4-ylü- (phenyl)imidazolin-2-onderivate als inhibitoren der p38-map-kinase zur behandlung von entzündlichen krankheiten
CY1107794T1 (el) Νeα μeθοδος παρασκευhς παραγωγων εποθιλονης
NO20000373D0 (no) Nye cyano-indol serotinin-reopptaks-inhibitorforbindelser, fremgangsmåte for deres fremstilling og farmasoeytiske sammensetninger inneholdende dem
HK1077520A1 (zh) 用作p38促细胞分裂原活化蛋白激酶抑制剂的吲哚类衍生物
Mashelkar et al. Synthesis of some novel 4-substituted coumarins having potential biological activity (Part III)
DK1116719T3 (da) 3-(1-hydroxy-pentyliden)-5-nitro-3H-benzofuran-2-on, fremgangsmåde til fremstilling deraf og anvendelse deraf
Abdel-Hafez Synthesis, Antimicrobial Activity of Some New 2-Amino-4-(4′-phenylsulfanyl-phenyl)-thiazole Derivatives and Theoretical Studies of Their Schiff's Base
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
Ashok et al. One pot multicomponent synthesis of 3′, 5-diaryl-1′-phenyl-3, 4-dihydro-1′ H, 2 H-3, 4′-bipyrazoles and their antimicrobial activity
Kriplani et al. Microwave assisted synthesis of some biologically active benzothiazolotriazine derivatives
Singh et al. The facile and efficient synthesis of novel monocyclic cis-β-lactam conjugates with a 1-methyl-1 H-imidazole-2-thiol nucleus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application